索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]谢燕青,李伟明.药物涂层球囊在冠状动脉小血管原发病变中的应用进展[J].国际心血管病杂志,2017,05:282-284.
点击复制

药物涂层球囊在冠状动脉小血管原发病变中的应用进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2017年05期
页码:
282-284
栏目:
综述
出版日期:
2017-10-20

文章信息/Info

Title:
-
作者:
谢燕青; 李伟明
200072 上海,同济大学附属第十人民医院心内科
Author(s):
-
关键词:
药物涂层球囊;  小血管原发病变;  冠状动脉
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2017.05.008
文献标识码:
-
摘要:
近年来,药物涂层球囊应用于冠状动脉介入治疗领域,已在支架内再狭窄和原发病变治疗方面积累了一些证据, 其在冠状动脉小血管原发病变中的疗效更值得期待。该文介绍药物涂层球囊的作用机制、特点,及其在冠状动脉小血管 原发病变的应用进展。
Abstract:
-

参考文献/References

[1] Kolh P, Windecker S, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization:the task force on myocardial revascularization of the European Society of Cardiology (ESC)and the European Association for Cardio-thoracic Surgery(EACTS).Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J]. Eur Heart J, 2014, 35(37):2541-2619.
[2] 中华医学会心血管病学分会介入心脏病学组. 中华心血管病杂志编辑委员会中国经皮冠状动脉介入治疗指南 (2016)[J]. 中华心血管病杂志, 2016, 44(5):382-400.
[3] Scheller B, Speck U, Romeike B, et al. Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model[J]. Eur Heart J, 2003, 24(15):1462-1467.
[4] Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis[J]. Circulation, 2004, 110(7):810-814.
[5] Xu B, Qian J, Ge J, et al. Two-year results and subgroup analyses of the PEPCAD China In-stent Restenosis Trial: a prospective,multicenter,randomized trial for the treatment of drug-eluting stent in -stent restenosis[J]. Cather Cardiovasc Interv, 2016, 87(Suppl 1):624-629.
[6] Habara S, Kadota K, Kanazawa T, et al. Paclitaxel-coated balloon catheter compared with drug- eluting stent for drug-eluting stent restenosis in routine clinical practice[J]. EuroIntervention, 2016, 11(10):1098-1105.
[7] Bajraktari G, Jashari H, Ibrahimi P, et al. Comparison of drug-eluting balloon versus drug-eluting stent treatment of drug-eluting stent in-stent restenosis: a meta-analysis of available evidence[J]. Int J Cardiol, 2016, 218(1):126-135.
[8] Alfonso F, García-Guimaraes M. Optimal coronary interventions in small vessels: is size all that matters?[J]. JACC Cardiovasc Interv, 2016, 9(13):1335-1337.
[9] Unverdorben M, Kleber FX, Heuer H, et al. Treatment of small coronary arteries with a paclitaxel- coated balloon catheter in the PEPCAD Ⅰ study: are lesions clinically stable from 12 to 36 months?[J]. EuroIntervention, 2013, 9(5):620-628.
[10] Naganuma T, Latib A, Sgueglia GA, et al. A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study[J]. Int J Cardiol, 2015, 184(1):17-21.
[11] Poerner TC, Otto S, Gassdorf J, et al. Stent coverage and neointimal proliferation in bare metal stents postdilated with a paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up[J]. Circ Cardiovasc Interv, 2014, 7(6):760-767.
[12] Otto S, Gassdorf J, Nitsche K, et al. Time course of vascular response after an a priori strategy of bare metal stent implantation post-dilated with a paclitaxel-coated balloon: implementation of a three-dimensional analysis algorithm with optical coherence tomography[J]. Cardiol J, 2016, 23(3):296- 306.
[13] Poerner TC, Duderstadt C, Goebel B, et al. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography[J]. Clin Res Cardiol, 2017, 106(1):18-27.
[14] Siontis GC, Piccolo R, Praz F, et al. Percutaneous coronary interventions for the treatment of stenoses in small coronary arteries: a network meta-analysis[J]. JACC Cardiovasc Interv, 2016, 9 (13):1324-1334.
[15] Kalra A, Rehman H, Khera S, et al. New-generation coronary stents: current data and future directions[J]. Curr Atheroscler Rep, 2017, 19(3):14.
[16] Sinaga DA, Ho HH, Watson TJ, et al. Drug-coated balloons: a safe and effective alternative to drug -eluting stents in small vessel coronary artery disease[J]. J Interv Cardiol, 2016, 29(5):454-460.
[17] Giannini F, Latib A, Ancona MB, et al. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels[J]. Catheter Cardiovasc Interv, 2017, Jan 21.[Epub ahead of print].
[18] Tanaka A, Jabbour RJ, Mitomo S, et al. Hybrid percutaneous coronary intervention with bioresorbable vascular scaffolds in combination with drug-eluting stents or drug-coated balloons for complex coronary lesions[J]. JACC Cardiovasc Interv, 2017, 10(6):539-547.

备注/Memo

备注/Memo:
通信作者:李伟明,Email:18917683469@189.cn
更新日期/Last Update: 2017-10-20